aibio
Debt Financing ·
Pharmaron agrees to issue RMB2,180 million convertible bonds
Pharmaron Beijing signed an agreement on August 26, 2026 for convertible bonds with an initial conversion price of HK$36.08 per H share.
300759 Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co. (300759) news 300759 convertible notes news
Latest Pharmaron Beijing Co. news
We have not published a story on Pharmaron Beijing Co. yet. When there is news, it will appear here.
Questions about Pharmaron Beijing Co.
Has Pharmaron Beijing Co. sold convertible notes?
Our latest story on this, dated Aug 27, 2026: "Pharmaron agrees to issue RMB2,180 million convertible bonds". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Pharmaron Beijing Co.?
Pharmaron Beijing Co., Ltd. trades under the ticker 300759 on SZSE.
Where is Pharmaron Beijing Co. listed?
Pharmaron Beijing Co., Ltd. is listed on SZSE. Our directory also records these other listings: GETTEX:17Q1; HKEX:3759; LSX:A2PV00.
Which country or territory is Pharmaron Beijing Co. listed under?
Our directory records Pharmaron Beijing Co., Ltd. under China.
What does Pharmaron Beijing Co. do?
Our directory classifies Pharmaron Beijing Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Pharmaron Beijing Co.?
The ISIN recorded for Pharmaron Beijing Co., Ltd. is CNE100003JW4.
Does aibio.space cover Pharmaron Beijing Co.?
aibio.space lists Pharmaron Beijing Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.
What is the latest Pharmaron Beijing Co. (300759) stock news?
Our latest story on Pharmaron Beijing Co., dated Aug 27, 2026: "Pharmaron agrees to issue RMB2,180 million convertible bonds". Pharmaron Beijing signed an agreement on August 26, 2026 for convertible bonds with an initial conversion price of HK$36.08 per H share. Source.
Which companies are similar to Pharmaron Beijing Co.?
Companies in our directory listed in the same country and business area as Pharmaron Beijing Co.: CASI Pharmaceuticals, Shanghai MicuRx Pharmaceutical Co., Jinling Pharmaceutical Co., PKU Healthcare Corp., Enwei Pharmaceutical Co., China National Accord Medicines Corporation.
How can I follow Pharmaron Beijing Co. (300759) news?
Press Follow on this page to add Pharmaron Beijing Co. to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Pharmaron Beijing Co. so far, in Debt Financing.
Investor discussion: Pharmaron Beijing Co.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- Pharmaron Beijing Co., Ltd.
- Ticker
- 300759
- Listing
- SZSE
- Country or territory
- China
- Business scope
- Pharmaceuticals: Major
- ISIN
- CNE100003JW4
- Other listed symbols
- GETTEX:17Q1; HKEX:3759; LSX:A2PV00
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction